Total Payments
$121,636
2024 Payments
$2,938
Companies
51
Transactions
1,376
Medicare Patients
13,362
Medicare Billing
$906,285
Payment Breakdown by Category
Other$87,665 (72.1%)
Food & Beverage$22,949 (18.9%)
Consulting$6,545 (5.4%)
Travel$3,072 (2.5%)
Research$1,160 (1.0%)
Education$245.58 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87,665 | 52 | 72.1% |
| Food and Beverage | $22,949 | 1,279 | 18.9% |
| Consulting Fee | $6,545 | 3 | 5.4% |
| Travel and Lodging | $3,072 | 20 | 2.5% |
| Unspecified | $1,160 | 9 | 1.0% |
| Education | $245.58 | 13 | 0.2% |
Payments by Type
General
$120,476
1,367 transactions
Research
$1,160
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $62,106 | 136 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $28,567 | 39 | $0 (2024) |
| Novo Nordisk Inc | $10,218 | 245 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $2,028 | 16 | $0 (2024) |
| Abbott Laboratories | $1,811 | 121 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,634 | 84 | $0 (2024) |
| Lilly USA, LLC | $1,585 | 98 | $0 (2024) |
| Insulet Corporation | $1,369 | 71 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,361 | 25 | $0 (2019) |
| SANOFI US SERVICES INC. | $1,160 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,938 | 150 | Abbott Laboratories ($383.54) |
| 2023 | $3,598 | 170 | Novo Nordisk Inc ($466.80) |
| 2022 | $19,039 | 200 | Bayer HealthCare Pharmaceuticals Inc. ($13,560) |
| 2021 | $16,642 | 127 | Bayer HealthCare Pharmaceuticals Inc. ($14,844) |
| 2020 | $12,081 | 88 | AstraZeneca Pharmaceuticals LP ($10,983) |
| 2019 | $19,498 | 222 | AstraZeneca Pharmaceuticals LP ($15,889) |
| 2018 | $24,487 | 240 | AstraZeneca Pharmaceuticals LP ($14,297) |
| 2017 | $23,354 | 179 | AstraZeneca Pharmaceuticals LP ($20,520) |
All Payment Transactions
1,376 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $31.30 | General |
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Insulin Pump | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Durable Pump | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: Rare Disease | ||||||
| 10/29/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: Insulin Pump | ||||||
| 10/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.08 | General |
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Durable Pump | ||||||
| 09/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Biological | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua?100/33 Versus Lantus? in Ethnically/Racially Di | SANOFI US SERVICES INC. | $1,160 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,571 | 2,504 | $468,093 | $189,758 |
| 2022 | 29 | 2,933 | 3,678 | $470,065 | $189,508 |
| 2021 | 33 | 4,399 | 7,300 | $632,812 | $258,937 |
| 2020 | 34 | 4,459 | 7,171 | $546,397 | $268,082 |
Total Patients
13,362
Total Services
20,653
Medicare Billing
$906,285
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 659 | 1,275 | $293,250 | $113,756 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 273 | $43,680 | $16,886 | 38.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 170 | 183 | $27,450 | $14,786 | 53.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 185 | $24,050 | $11,733 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 125 | 125 | $25,015 | $10,336 | 41.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 155 | 288 | $18,720 | $7,434 | 39.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 49 | 50 | $12,000 | $4,610 | 38.4% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 40 | 41 | $8,815 | $4,524 | 51.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,900 | $1,720 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,260 | $1,668 | 39.2% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 18 | 41 | $4,613 | $1,449 | 31.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,340 | $855.00 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 500 | 715 | $164,450 | $70,827 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 579 | 785 | $125,600 | $44,241 | 35.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 109 | 248 | $32,240 | $13,996 | 43.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 136 | 145 | $21,750 | $11,400 | 52.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 123 | 123 | $24,600 | $10,233 | 41.6% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 58 | 61 | $13,115 | $6,992 | 53.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 117 | 201 | $13,065 | $5,360 | 41.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 40 | 42 | $10,080 | $4,597 | 45.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $6,745 | $2,860 | 42.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 144 | 151 | $9,083 | $2,532 | 27.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 37 | 37 | $4,810 | $1,974 | 41.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 127 | 133 | $6,381 | $1,777 | 27.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,080 | $1,742 | 42.7% |
About Dr. Khurram Wadud, M.D
Dr. Khurram Wadud, M.D is a Specialist healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801877576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khurram Wadud, M.D has received a total of $121,636 in payments from pharmaceutical and medical device companies, with $2,938 received in 2024. These payments were reported across 1,376 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,665).
As a Medicare-enrolled provider, Wadud has provided services to 13,362 Medicare beneficiaries, totaling 20,653 services with total Medicare billing of $906,285. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism
- Location Jacksonville, FL
- Active Since 11/09/2005
- Last Updated 02/04/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1801877576
Products in Payments
- FARXIGA (Drug) $53,087
- Kerendia (Drug) $28,567
- BYDUREON (Drug) $8,908
- Victoza (Drug) $5,944
- Rybelsus (Drug) $2,314
- t-slim insulin pump (Device) $1,915
- SOLIQUA (Drug) $1,390
- Minimed 670G System (Device) $1,387
- Omnipod (Device) $1,369
- JARDIANCE (Drug) $1,274
- Ozempic (Drug) $735.71
- AFREZZA (Drug) $674.73
- UNITHROID (Drug) $670.74
- FREESTYLE LIBRE 3 (Device) $590.16
- Dexcom G6 Transmitter (Medical Supply) $587.22
- TEPEZZA (Drug) $575.02
- FreeStyle Libre (Device) $564.32
- Tymlos (Biological) $491.68
- JANUVIA (Drug) $385.37
- GVOKE PFS (Drug) $343.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Jacksonville
Dr. Andrew Cannestra, Md, MD
Specialist — Payments: $1.6M
Specialist $1.6M
Dr. David Sutton, M.d, M.D
Specialist — Payments: $1.3M
Specialist $1.3M
Richard Heekin, Md, MD
Specialist — Payments: $173,723
Specialist $173,723
Dr. Arun Gulani, M.d, M.D
Specialist — Payments: $129,235
Specialist $129,235
Dr. J Magee, M.d, M.D
Specialist — Payments: $116,429
Specialist $116,429
Dr. Mary Pentel, M.d, M.D
Specialist — Payments: $60,033
Specialist $60,033